psychiatrists seeing increasing numbers male patients treated low testosterone symptoms low promoted reason get assessed treated testosterone surprisingly low highly successful pharmaceutical company promotion successful testosterone seems disappeared vernacular replaced i opportunity follow controversy last years back days subgroup psychiatrists considered microendocrinologists testosterone lh fsh gnrh studied along components hypothalamic pituitary adrenal hypothalamic pituitary thyroid axes particularly depressives despite lengthy low intensity research effort gonadal steroids men women data baseline neuroendocrine correlates results supplemental treatments equivocal said psychiatrists encountered women often significant response treatment gonadal steroids seeing consistent treatment effect difficult clinical psychiatrist i found clearest information drugs available fda approved package insert case product marketed low ads form testosterone gel available two different strengths indication product according package insert primary hypogonadism congenital acquired hypogonadotropic hypogonadism congential acquired use treating depression augmenting antidepressants label use testosterone effective augmenting agent would join ranks antidepressant augmenting agents label prescription three related issues first diagnosis primary hypogonadotropic hypogonadism cases speculation would middle aged man sees hears low ad goes see primary care physician testosterone level ordered authoritative sources like uptodate state testosterone replacement occur men hypogonadal making determination generally requires two low testosterone levels indeterminant cases expertise hypothalamic pituitary gonadal axis hpg well access laboratory specialized endocrine capabilities level assessments seem break range i used seeing total testosterone levels ranging ng ml scattergrams testosterone versus behavioral parameters interest like libido aggression energy usually show low levels correlation many men getting treated like commercial suggests low testosterone level low normal range deficient range takes treatment realm label indications diagnosis hypogonadism definitive algorithm endocrinologists available including refer endocrinologist second issue whether evidence testosterone either treats depression effective agent augment effects antidepressants would conceivably move testosterone level augmenting agents used star study depression best guidance literature comes pope et al article testosterone replacement men years age younger taking serotonergic antidepressants total testosterone level less equal ng ml psa less ng ml incomplete response antidepressant author conclude significant differences response testosterone placebo gel conclusion current practice testosterone supplementation antidepressants supported may identifiable subgroups larger studies pope observations also critical expert anabolic androgenic steroid aas abuse observed euphorigenic hypomanic response aas prescription testosterone article cites response occurring volunteers taking equivalent mg week testosterone equivalent observations critical factor addictive behaviors associated substance use pope group proposed criteria anabolic androgenic steroid dependence criteria highlight fact number associated mood symptoms including depression withdrawal phase screening aas use disorder associated comorbidity like muscle dysmorphia third issue risk benefit analysis makes testosterone augmenting agent unique star agents testosterone unique medical risks beyond risk additive effect antidepressant main risk augmenting agents usually rare cases serotonin syndrome side effects specific agent essentially prescribed indication testosterone professional body advocating supplementation men eugonadal state risks may significant starting contraindications breast cancer known suspected prostate cancer warnings benign prostatic hypertrophy exposure women children edema sleep apnea need monitor number biochemical parameters also recent articles showing possible correlation number concerns increased myocardial infarction ischemic stroke mortality psychiatrists referred men treated low sent question testosterone couple necessary steps point make sure diagnosis hypogonadism established let patient know testosterone supplementation antidepressants eugonadal men time experimental carries risks i would also inquire past history anabolic androgenic steroid use conscious experience use ranging mood changes body image concerns prior psychiatric history including history addictions using performance enhancing drugs men considering evaluation treatment low much complex filling online questionnaire pharmaceutical company website realistic expectations expect especially someone suggesting testosterone supplementation treatment depression take good look risk consider probably never major study takes good look issue large population men prospective studies probably similar pope et al men followed short period time retrospective studies innovative designs also limited selection factors significant stratification factors generally means additional information risk may available form fda warnings post marketing surveillance analysis data may publicly available george dawson md dfapa references dandona p rosenberg mt practical guide male hypogonadism primary care setting clin pract may doi review pubmed pmid pubmed central pmcid pmc pope hg jr amiaz r brennan bp orr weiser kelly jf kanayama siegel hudson ji seidman sn parallel group placebo controlled trial testosterone gel men major depressive disorder displaying incomplete response standard antidepressant treatment clin psychopharmacol apr doi jcp bedca pubmed pmid vigen r donnell ci bar ae et al association testosterone therapy mortality myocardial infarction stroke men low testosterone levels jama basaria coviello ad travison tg et al adverse events associated testosterone administration engl med jul doi nejmoa epub jun pubmed pmid pubmed central pmcid pmc cappola testosterone therapy risk cardiovascular disease men jama nov doi jama pubmed pmid tip follow lead authors references medline comprehensive look literature area